Based on recent data, Kura Oncology, Inc. (KURA) shows an Average True Range (ATR) of 0.58 and an Enterprise Value of 1.41B. Its average trading volume over the past 3 months is 1.84M, indicating liquidity. These fundamental metrics provide insight into KURA's underlying financial health and market activity.
| ATR | 0.58 |
| Enterprise Value | 1.41B |
| Avg Vol (3 Months) | 1.84M |
| Avg Vol (10 Days) | 1.78M |
Kura Oncology, Inc. (KURA) technical indicators as of January 11, 2026: the SMA 20 is -8.15%, SMA 50 at -11.81%, and SMA 200 at 18.08%. The RSI 14 value is 39.28, suggesting its current momentum. These technical analysis signals help assess KURA's price trends and potential future movements.
| SMA 20 | -8.15% |
| SMA 50 | -11.81% |
| SMA 200 | 18.08% |
| RSI 14 | 39.28 |
Kura Oncology, Inc. (KURA) stock performance overview as of January 11, 2026: The 52-week high is $12.49 (currently -24.66% below), and the 52-week low is $5.41 (currently 73.94% above). Over the past year, KURA's performance is 10.02%, compared to the S&P 500's 12.34% change.
| 52-Week High | 12.49 |
| 52-Week High Chg | -24.66% |
| 52-Week Low | 5.41 |
| 52-Week Low Chg | +73.94% |
| S&P 500 52-Week Chg | 12.34% |
According to market data, Kura Oncology, Inc. (KURA) stock's recent performance metrics show that over the last month, KURA is -20.08%, with a Year-to-Date (YTD) performance of -8.08%. Over the past year, the stock has seen a 10.02% change. These figures summarize KURA's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 10.43 | 11.6 | 12.49 | 12.49 | 12.49 | 10.51 |
| Low | 9.24 | 9.24 | 8.83 | 5.45 | 5.41 | 9.24 |
| Performance | -8.08% | -20.08% | +1.27% | +55.03% | +10.02% | -8.08% |
According to current financial data, KURA stock's P/E (TTM) ratio is -3.80, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for KURA, including P/S (7.87), P/B (3.40), and P/FCF (9.85), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | KURA | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -3.8 | -1.24 | -5.16 | 32.59 |
| P/S (TTM) | 7.87 | 3.71 | 465.9 | 5.98 |
| P/B (TTM) | 3.4 | 0.19 | -335.2 | 6.24 |
| P/FCF (TTM) | 9.85 | -3.62 | -394.53 | 36.55 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep